These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36959867)

  • 1. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
    Sahay S; Villasmil Hernandez N; Wang F; Wooten M; Nguyen DT; Fauvel C; Benza R; Graviss EA
    Chest; 2024 Aug; 166(2):373-387. PubMed ID: 38447640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
    Benza RL; Gomberg-Maitland M; Elliott CG; Farber HW; Foreman AJ; Frost AE; McGoon MD; Pasta DJ; Selej M; Burger CD; Frantz RP
    Chest; 2019 Aug; 156(2):323-337. PubMed ID: 30772387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of risk assessment tools in predicting hemodynamic outcome after balloon pulmonary angioplasty: a comparative analysis.
    Li X; Zhang Y; Zhao Q; Yang T; Zeng Q; Jin Q; Duan A; Huang Z; Hu M; Zhang S; Gao L; Xiong C; Luo Q; Zhao Z; Liu Z
    Postgrad Med; 2024 May; 136(4):446-455. PubMed ID: 38785198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.
    Yogeswaran A; Gall H; Fünderich M; Wilkins MR; Howard L; Kiely DG; Lawrie A; Hassoun PM; Sirenklo Y; Torbas O; Sweatt AJ; Zamanian RT; Williams PG; Frauendorf M; Arvanitaki A; Giannakoulas G; Saleh K; Sabbour H; Cajigas HR; Frantz R; Al Ghouleh I; Chan SY; Brittain E; Annis JS; Pepe A; Ghio S; Orfanos S; Anthi A; Majeed RW; Wilhelm J; Ghofrani HA; Richter MJ; Grimminger F; Sahay S; Tello K; Seeger W;
    Chest; 2024 Sep; 166(3):585-603. PubMed ID: 38508334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
    Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Park DH; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Lange TJ; Rosenkranz S
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34737226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk stratification in pulmonary arterial hypertension - implementation of an internet-based risk calculator to guide treatment].
    Ahmed A; Ahmed S; Rådegran G
    Lakartidningen; 2023 Oct; 120():. PubMed ID: 37870224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation effect of COMPERA 2.0 risk assessment model on prognosis of Chinese patients with pulmonary arterial hypertension].
    Liang YR; Yang YC; Yang BL; Zeng QX; Liu BY; Zhao Q; Luo Q; Zhao ZH; Yang T; Liu ZH; Xiong CM
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(18):1410-1416. PubMed ID: 37150694
    [No Abstract]   [Full Text] [Related]  

  • 9. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension.
    Cruz-Utrilla A; Gallego-Zazo N; Pérez-Olivares C; Hernández-González I; Bedate P; Martínez Meñaca A; López Meseguer M; Lapunzina P; Pérez Núñez M; Ochoa Parra N; Valverde D; Tenorio-Castaño JA; Escribano-Subias P
    Rev Esp Cardiol (Engl Ed); 2023 Jun; 76(6):460-467. PubMed ID: 36403940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Brown Z; Hansen D; Stevens W; Ferdowsi N; Ross L; Quinlivan A; Sahhar J; Ngian GS; Apostolopoulos D; Walker JG; Proudman S; Teng GG; Low AHL; Morrisroe K; Nikpour M
    Arthritis Care Res (Hoboken); 2024 Jul; 76(7):973-983. PubMed ID: 38523256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Hoeper MM; Kramer T; Pan Z; Eichstaedt CA; Spiesshoefer J; Benjamin N; Olsson KM; Meyer K; Vizza CD; Vonk-Noordegraaf A; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Huscher D; Pittrow D; Rosenkranz S; Grünig E
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.
    Vicenzi M; Caravita S; Rota I; Casella R; Deboeck G; Beretta L; Lombi A; Vachiery JL
    PLoS One; 2022; 17(5):e0265059. PubMed ID: 35587927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Risk Stratification Scores in Pulmonary Arterial Hypertension: A Monocentric Retrospective Study at Lausanne University Hospital.
    Vraka A; Yerly P; Aubert JD
    Respiration; 2022; 101(6):565-576. PubMed ID: 35045412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry.
    Kaemmerer AS; Gorenflo M; Huscher D; Pittrow D; Ewert P; Pausch C; Delcroix M; Ghofrani HA; Hoeper MM; Kozlik-Feldmann R; Skride A; Stähler G; Vizza CD; Jureviciene E; Jancauskaite D; Gumbiene L; Ewert R; Dähnert I; Held M; Halank M; Skowasch D; Klose H; Wilkens H; Milger K; Jux C; Koestenberger M; Scelsi L; Brunnemer E; Hofbeck M; Ulrich S; Vonk Noordegraaf A; Lange TJ; Bruch L; Konstantinides S; Claussen M; Löffler-Ragg J; Wirtz H; Apitz C; Neidenbach R; Freilinger S; Nemes A; Opitz C; Grünig E; Rosenkranz S
    Cardiovasc Diagn Ther; 2021 Dec; 11(6):1255-1268. PubMed ID: 35070795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
    Stolfo D; Barbisan D; Ameri P; Lombardi CM; Monti S; Driussi M; Zovatto IC; Gentile P; Howard L; Toma M; Pagnesi M; Collini V; Bauleo C; Guglielmi G; Adamo M; D'Angelo L; Nalli C; Sciarrone P; Moschella M; Zorzi B; Vecchiato V; Milani M; Di Poi E; Airò E; Metra M; Garascia A; Sinagra G; Lo Giudice F
    J Heart Lung Transplant; 2023 Aug; 42(8):1082-1092. PubMed ID: 37005100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early risk prediction in idiopathic
    Hjalmarsson C; Kjellström B; Jansson K; Nisell M; Kylhammar D; Kavianipour M; Rådegran G; Söderberg S; Wikström G; Wuttge DM; Hesselstrand R
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34350280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and risk assessment in pulmonary veno-occlusive disease.
    Boucly A; Solinas S; Beurnier A; Jaïs X; Keddache S; Eyries M; Seferian A; Jevnikar M; Roche A; Bulifon S; Bourdin A; Chaouat A; Cottin V; Bertoletti L; Savale L; Humbert M; Sitbon O; Montani D
    ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38226059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification in pulmonary arterial hypertension using Bayesian analysis.
    Kanwar MK; Gomberg-Maitland M; Hoeper M; Pausch C; Pittrow D; Strange G; Anderson JJ; Zhao C; Scott JV; Druzdzel MJ; Kraisangka J; Lohmueller L; Antaki J; Benza RL
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32366491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.